Silverleafe Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
OKLO
Oklo
OKLO
|
+$2.5M |
| 2 |
Palantir
PLTR
|
+$1.51M |
| 3 |
Core Scientific
CORZ
|
+$1.27M |
| 4 |
TEM
Tempus AI
TEM
|
+$1.24M |
| 5 |
Arcutis Biotherapeutics
ARQT
|
+$1.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$916K |
| 2 |
iShares Core Universal USD Bond ETF
IUSB
|
+$743K |
| 3 |
2x Bitcoin ETF
BITX
|
+$626K |
| 4 |
Conagra Brands
CAG
|
+$549K |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$503K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.21% |
| 2 | Financials | 8.43% |
| 3 | Industrials | 7.34% |
| 4 | Consumer Staples | 7.09% |
| 5 | Consumer Discretionary | 4.59% |
Similar funds
Silverleafe Capital Partners's Q4 2025 Portfolio in Review
As of Q4 2025, Silverleafe Capital Partners held 107 positions worth $337M, up 3.2% from $327M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Silverleafe Capital Partners deployed $13.9M of net new capital in Q4 2025, opening 15 new positions and adding to 38 existing holdings. Its largest new stake was Core Scientific: 72,950 shares worth $1.06M.
By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 8% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was iShares Core Universal USD Bond ETF, an estimated $743K trimmed.
- Silverleafe Capital Partners's largest Q4 2025 buy was Core Scientific: 72,950 shares worth $1.06M.
- Silverleafe Capital Partners added most to Oklo in Q4 2025, an estimated $2.5M increase.
- Silverleafe Capital Partners's biggest Q4 2025 reduction was iShares Core Universal USD Bond ETF, cutting an estimated $743K.
- Silverleafe Capital Partners fully exited Bristol-Myers Squibb in Q4 2025, selling an estimated $916K.
- Silverleafe Capital Partners's ten largest holdings make up 56% of its $337M portfolio in Q4 2025.
- Silverleafe Capital Partners opened 15 new positions and closed 9 in Q4 2025.
- Silverleafe Capital Partners's portfolio value rose 3.2% quarter-over-quarter to $337M.
Based on Silverleafe Capital Partners's 13F filing for Q4 2025, filed 12 Jan 2026.